Bisarylamines
    3.
    发明授权
    Bisarylamines 失效
    二芳基胺

    公开(公告)号:US4795757A

    公开(公告)日:1989-01-03

    申请号:US932557

    申请日:1986-11-20

    摘要: Compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, wherein: Ar is phenyl, naphthyl, heteroaryl, indole, or fused arylcycloalkyl optionally substituted with hydroxy, halo, CF.sub.3, NO.sub.2, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or aryloxy;A and A' are each hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, hydroxy or aryloxy;X is cyano, nitro, COOR, SR, SOR or SOOR;R is H, C.sub.1-6 alkyl or aryl;n n' and n" are each 0 to 4; andm, m' and m" are each 1 to 4, have calcium channel blocking activity.

    摘要翻译: 其中:Ar为任选被羟基取代的苯基,萘基,杂芳基,吲哚或稠合的芳基环烷基,其中R 1,R 2,R 3,R 4, ,CF 3,NO 2,C 1-6烷基,C 1-6烷氧基或芳氧基; A和A'各自为氢,C 1-6烷基,C 1-6烷氧基,羟基或芳氧基; X是氰基,硝基,COOR,SR,SOR或SOOR; R为H,C 1-6烷基或芳基; n n和n“分别为0〜4; m,m'和m“各自为1〜4,具有钙通道阻断活性。

    Method of using phenyl-alkylene-2-pyridyl derivatives to increase
cardiac contractility in a mammal
    4.
    发明授权
    Method of using phenyl-alkylene-2-pyridyl derivatives to increase cardiac contractility in a mammal 失效
    使用苯基 - 亚烷基-2-吡啶基衍生物增加哺乳动物心脏收缩力的方法

    公开(公告)号:US4569941A

    公开(公告)日:1986-02-11

    申请号:US692602

    申请日:1985-01-17

    CPC分类号: C07D207/08 C07D211/22

    摘要: Compounds of the formulae: ##STR1## wherein, Z and Y are each alkylene or oxy-alkylene containing one to about five carbon atoms in the principal chain or said alkylene substituted with OH, alkanoyloxy, alkoxy, mercapto or alkylmercapto;each of R.sub.1, R.sub.2 and R.sub.3 is independently H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfinyl, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino, or acylamino; or R.sub.1 and R.sub.2, when taken together, form a methylenedioxy or --O--CO--O--;Ar is heteroaryl, cycloalkyl or ##STR2## wherein, R.sub.1, R.sub.2 and R.sub.3 are as hereindescribed; andR is H, alkyl, cycloalkyl, aryl, aralkyl, alkenyl, alkynyl, carboalkoxy, or CONR.sub.4 R.sub.5 wherein each of R.sub.4 and R.sub.5 is H or alkyl; wherein the total number of carbon atoms in each hydrocarbyl group is up to 10; and ##STR3## wherein, each of R.sub.1 and R.sub.2 is independently H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfinyl, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino, or acylamino; or R.sub.1 and R.sub.2, when taken together, form a methylenedioxy, or --O--CO--O--; R.sub.6 is H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino or acylamino; wherein the total number of carbon atoms in each hydrocarbyl group is up to 10; and acid addition salts thereof have selective cardiotonic, antihypertensive and antiallergic activity.

    摘要翻译: 下式的化合物:其中Z和Y分别是在主链中含有一至五个碳原子的亚烷基或氧代 - 亚烷基或被OH,烷酰氧基,烷氧基,巯基或烷基巯基取代的所述亚烷基; R 1,R 2和R 3各自独立地是H,烷基,芳基,卤素,烷氧基,烯氧基,烷基亚磺酰基,烷基磺酰基,烷基巯基,氰基,羧基,烷氧基,甲酰胺基,氨磺酰基,三氟甲基,羟基,羟基烷基,酰氧基,烷基氨基,磺酰基氨基或 酰氨基; 当R 1和R 2一起形成亚甲二氧基或-O-CO-O-时; Ar是杂芳基,环烷基或者其中R 1,R 2和R 3如以下所示: 并且R为H,烷基,环烷基,芳基,芳烷基,烯基,炔基,烷氧羰基或CONR4R5,其中R4和R5各自为H或烷基; 其中每个烃基中的碳原子总数最多为10; 其中,R1和R2各自独立地为H,烷基,芳基,卤素,烷氧基,烯氧基,烷基亚磺酰基,烷基磺酰基,烷基巯基,氰基,羧基,烷氧基,甲酰氨基,氨磺酰基,三氟甲基,羟基, ,酰氧基,烷基氨基,磺酰基氨基或酰基氨基; 当R 1和R 2一起形成亚甲二氧基或-O-CO-O-时; R 6是H,烷基,芳基,卤素,烷氧基,烯氧基,烷基磺酰基,烷基巯基,氰基,羧基,烷氧基,甲酰胺基,氨磺酰基,三氟甲基,羟基,羟基烷基,酰氧基,烷基氨基,磺酰基氨基或酰基氨基; 其中每个烃基中的碳原子总数最多为10; 其酸加成盐具有选择性强心药,抗高血压药和抗过敏活性。

    Pyrrolidines
    9.
    发明授权
    Pyrrolidines 失效
    吡咯烷

    公开(公告)号:US4342692A

    公开(公告)日:1982-08-03

    申请号:US198671

    申请日:1980-10-20

    摘要: Compounds of the formulae: ##STR1## wherein, Z and Y are each alkylene containing one to about five carbon atoms in the principal chain or said alkylene substituted with OH, alkanoyloxy, alkoxy, mercapto or alkylmercapto;each of R.sub.1, R.sub.2 and R.sub.3 is independently H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfinyl, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino, or acylamino; and R.sub.1 and R.sub.2, when taken together, form a methylenedioxy or --O--CO--O--;Ar is heteroaryl, cycloalkyl or ##STR2## wherein, R.sub.1, R.sub.2 and R.sub.3 are as hereindescribed; andR is H, alkyl, cycloalkyl, aryl, aralkyl, alkenyl, alkynyl, carboalkoxy, or CONR.sub.4 R.sub.5 wherein each of R.sub.4 and R.sub.5 is H or alkyl; wherein the total number of carbon atoms in each hydrocarbyl group is up to 10;and ##STR3## wherein, each of R.sub.1 and R.sub.2 is independently H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfinyl, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino, or acylamino; and R.sub.1 and R.sub.2, when taken together, form a methylenedioxy, or --O--CO--O--; R.sub.6 is H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino or acylamino; wherein the total number of carbon atoms in each hydrocarbyl group is up to 10; and acid addition salts thereof have selective cardiotonic, antihypertensive and antiallergic activity.

    摘要翻译: 下式的化合物:其中Z和Y分别是在主链中含有1至约5个碳原子的亚烷基或被OH,烷酰氧基,烷氧基,巯基或烷基巯基取代的所述亚烷基; R 1,R 2和R 3各自独立地是H,烷基,芳基,卤素,烷氧基,烯氧基,烷基亚磺酰基,烷基磺酰基,烷基巯基,氰基,羧基,烷氧基,甲酰胺基,氨磺酰基,三氟甲基,羟基,羟基烷基,酰氧基,烷基氨基,磺酰基氨基或 酰氨基; 当R 1和R 2一起形成亚甲二氧基或-O-CO-O-时; Ar是杂芳基,环烷基或者其中R 1,R 2和R 3如以下所示: 并且R为H,烷基,环烷基,芳基,芳烷基,烯基,炔基,烷氧羰基或CONR4R5,其中R4和R5各自为H或烷基; 其中每个烃基中的碳原子总数最多为10; 其中,R1和R2各自独立地为H,烷基,芳基,卤素,烷氧基,烯氧基,烷基亚磺酰基,烷基磺酰基,烷基巯基,氰基,羧基,烷氧基,甲酰氨基,氨磺酰基,三氟甲基,羟基, ,酰氧基,烷基氨基,磺酰基氨基或酰基氨基; 当R 1和R 2一起形成亚甲二氧基或-O-CO-O-时; R 6是H,烷基,芳基,卤素,烷氧基,烯氧基,烷基磺酰基,烷基巯基,氰基,羧基,烷氧基,甲酰胺基,氨磺酰基,三氟甲基,羟基,羟基烷基,酰氧基,烷基氨基,磺酰基氨基或酰基氨基; 其中每个烃基中的碳原子总数最多为10; 其酸加成盐具有选择性强心药,抗高血压药和抗过敏活性。